Episode Summary
Executive Summary: Goldman Sachs strategist David Kostin says the Pfizer vaccine news mattered more than the election, because it creates a path to economic normalization, stronger 2021 growth, and higher equities. He argues divided government reduces policy uncertainty, supports the market, and shifts leadership beyond mega-cap tech toward cyclical and value sectors like healthcare, while keeping risks centered on COVID, leverage, and insufficient fiscal support.
Main Topics: Vaccine breakthrough as the dominant market catalyst (Priority: 5/5): Kostin emphasizes that the Pfizer vaccine announcement is more important than the election because it provides a credible path toward normal economic activity, faster growth, and a broad equity rally. Election outcome and policy uncertainty (Priority: 4/5): A likely divided government reduces uncertainty and lowers the probability of major tax or stimulus changes, which the market views positively for valuations. S&P 500 outlook for 2020 and 2021 (Priority: 5/5): Goldman maintained a 3,700 year-end 2020 target and raised its 2021 target to 4,300, implying meaningful upside driven by earnings recovery and low rates. Market concentration and broadening leadership (Priority: 4/5): Kostin notes unprecedented concentration in the five largest tech stocks and expects broader participation from the median stock next year as the market normalizes. Sector rotation, especially healthcare (Priority: 4/5): Healthcare is presented as a key value opportunity because its relative valuation is at a 40-year low and the sector often performs better after elections. Consensus gap and earnings expectations (Priority: 4/5): Goldman’s earnings forecast is above consensus, based on stronger vaccine-led recovery and continued low interest rates, which should support equity prices. Risks to the outlook (Priority: 4/5): Primary downside risks are worsening COVID cases, corporate leverage, and inadequate fiscal stimulus to bridge households and businesses through the recovery.
Key Arguments: The vaccine is more important than the election because public health resolution is necessary for economic normalization. Divided government reduces policy uncertainty and lowers the likelihood of major tax or fiscal legislation, which supports valuations. A vaccine-enabled recovery should drive strong 2021 GDP/earnings growth and justify higher equity prices. Market leadership should broaden beyond the five mega-cap tech names to more typical S&P 500 stocks. Healthcare looks attractive because it is unusually cheap relative to the broader market and may benefit after election-related uncertainty clears. Goldman’s earnings forecast is above consensus because it assumes effective vaccine rollout and sustained low interest rates. Main risks are continued virus spread, corporate balance-sheet strain, and insufficient fiscal aid.
Data Points: S&P 500 year-end 2020 target: 3,700 - Goldman Sachs maintained this forecast after the election/vaccine developments. S&P 500 year-end 2021 target: 4,300 - Goldman Sachs outlook for the end of 2021. Implied equity return: ~20% - Kostin said the 2021 target implies nearly 20% return over about 14 months from the current level. Year-end 2020 upside: ~4% - He described 3,700 as roughly 4% upside from the level at the time of recording. Big Tech concentration: ~25% of the S&P 500 - Five stocks—Facebook, Amazon, Apple, Microsoft, and Google—represent nearly a quarter of the index. Big Tech performance YTD: ~50% - The five largest stocks were up nearly 50% since the start of 2020. Other 495 stocks performance YTD: ~4% - The rest of the S&P 500 was only up around 4%. Healthcare valuation discount: Lowest relative valuation in 40 years - Kostin highlighted healthcare as historically cheap versus the market. Goldman S&P 500 earnings forecast: $175 - Goldman’s estimate for next year’s S&P 500 earnings. Other strategists' earnings forecast: $155 - Average forecast among other strategists. Sell-side analyst community earnings forecast: $168 - Average forecast across the broader analyst community. Forecast gap vs strategists: ~13% - Goldman’s earnings estimate was about 13% above other strategists. Forecast gap vs analyst community: ~5% - Goldman’s earnings estimate was about 5% above the broader analyst community. Timing reference for vaccine expectation: Late November - He said the market had expected vaccine news somewhat later than it arrived. Expected congressional uncertainty resolution: January 5 - Kostin said the control-of-Congress uncertainty would not be resolved until that date.
Pivotal Quotes: "the vaccine was much more important than the election" — David Kostin: He framed the vaccine news as the key driver for markets and the economy. "this was and is a public health crisis that started nearly a year ago" — David Kostin: He explained why a medical advance is central to economic normalization. "We have a 4,300 target at the end of 2021" — David Kostin: He presented Goldman Sachs’ bullish S&P 500 forecast for next year.
Implications: Investors should expect a recovery-led market with broader sector participation, more value/cyclical leadership, and continued support from low rates. The main watch points are vaccine rollout, fiscal aid, and whether COVID or leverage delays normalization.
About Goldman Sachs Exchanges
In each episode of "Exchanges," people from the firm share their insights on developments shaping industries, markets and the global economy.